Deliberate Dysentery
Codon
JANUARY 21, 2024
People are hesitant to do this because it's not a particularly flashy disease to research, nor is this population the focus of major pharmaceutical companies. There have been deaths in phase 1 medical and drug research among healthy participants. Is it cheaper to develop a drug or a vaccine through standard trials or challenge trials?
108 
Let's personalize your content